Quarterly Result29 May 2026, 07:32 pm
Kabra Drugs FY26: Revenue from Operations at ₹9,274 Lakhs
AI Summary
Kabra Drugs Ltd has announced its audited financial results for the quarter and year ended March 31, 2026. The Board of Directors approved the financial statements on May 29, 2026. Revenue from Operations stood at ₹9,274 lakhs for the financial year ended March 31, 2026. Net Profit after Tax is ₹495.98 lakhs. The company has restated comparative quarterly figures due to the impact of Ind AS 116.
Key Highlights
- Revenue from Operations for FY26 reached ₹9,274 lakhs.
- Net Profit after Tax for FY26 is reported at ₹495.98 lakhs.
- The Board approved audited financial statements on May 29, 2026.
- Figures restated due to impact of Ind AS 116.
Price Impact
More from KABRADG